Tag: precision oncology
-
Changing the Narrative: Calgary’s New Sarcoma Breakthroughs Through iSARP
Changing the Narrative in Calgary’s Cancer Care When Dr. Michael Monument returned to his hometown of Calgary in 2014 after a fellowship at the University of Utah, he faced a challenge that would shape the next decade of cancer research in the city. Sarcoma, a relatively rare but devastating group of bone and soft tissue…
-
Changing the narrative: Calgary’s new frontier in sarcoma therapy
Changing the Narrative: Calgary’s Leap into Sarcoma Innovation When Dr. Michael Monument returned to his hometown of Calgary in 2014 after a fellowship at the University of Utah, colleagues warned that the city might not be a natural home for sarcoma research. Sarcoma—an often rare cancer that targets bone and soft tissues and frequently affects…
-
Changing the Narrative: How Calgary’s iSARP Is Redefining Sarcoma Therapy
Changing the Narrative in Calgary’s Medical Landscape When Dr. Michael Monument returned to his hometown of Calgary in 2014 after a fellowship at the University of Utah, colleagues warned him that the city might not be the best place to pursue sarcoma research. Sarcoma, a relatively rare family of bone and soft tissue tumors that…
-
Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early Breast Cancer
Introduction: A new twist in tamoxifen treatment Breast cancer remains the most commonly diagnosed cancer among women worldwide. In a decisive step toward more effective hormone therapy, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) has unveiled TAMENDOX, a personalized treatment strategy designed to optimize tamoxifen’s impact for individual patients. This multicenter clinical study…
-
Pan-Cancer AI Model Improves Prognostic Accuracy Across Cancers
A New Milestone in Pan-Cancer Prognosis Researchers have unveiled a multimodal artificial intelligence model that advances prognosis prediction across a broad spectrum of cancers. Known as MICE (Multimodal data Integration via Collaborative Experts), the framework fuses pathology images, genomic information, and clinical data to deliver more accurate survival predictions across 30 distinct cancer types. The…
-
Pan-Cancer Prognosis AI Model Boosts Accuracy Across Cancers
Introduction: A New Era in Pan-Cancer Prognosis Recent advances in artificial intelligence are reshaping how clinicians predict cancer outcomes. A multimodal AI model named MICE (Multimodal data Integration via Collaborative Experts) has demonstrated notable improvements in pan-cancer prognosis prediction. By integrating pathology images, genomics, and clinical data, MICE shows strong generalizability across 30 cancer types,…
-
Ireland Advances Phase 2 of National Precision Oncology Program to Personalize Cancer Care
Ireland launches Phase 2 of its national precision oncology program On 8 October, Ireland marked a significant milestone in its fight against cancer as Minister for Further and Higher Education, Research, Innovation and Science James Lawless TD unveiled Phase 2 of Precision Oncology Ireland (POI). This country-wide effort stands as the largest and most ambitious…
-
Ireland launches Phase 2 of national Precision Oncology program to accelerate personalized cancer care
Ireland marks a new chapter in personalized cancer care with Phase 2 of Precision Oncology Ireland On 8 October, Ireland strengthened its commitment to precision medicine with the launch of Phase 2 of Precision Oncology Ireland (POI), the country’s leading and largest cancer research program. The initiative, announced by James Lawless TD, Minister for Further…
-
Ireland Expands Precision Oncology Ireland: Phase 2 Launch Poised to Transform Cancer Care
Ireland Launches Phase 2 of its National Precision Oncology Program On 8 October, Ireland marked a significant milestone in its fight against cancer with the launch of Phase 2 of Precision Oncology Ireland (POI). The event signals a bold expansion of the country’s leading cancer research program, built to advance personalised cancer research and patient…
-
Ireland launches phase 2 of €28m Precision Oncology Ireland programme to accelerate personalised cancer care
Phase 2 kicks off for Ireland’s largest cancer research initiative Ireland’s leading cancer research programme, Precision Oncology Ireland (POI), has received a €28 million co-funding boost to move into its second phase. The expansion aims to scale the collaborative model established in POI’s inaugural phase and to deepen ties between researchers, clinicians, industry partners, charities,…